Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma

Tony S.K. Mok, Tsai Shen Yang, Yee Chao, Cheng Hsu Wang, Mei Ching Liu, Yoon Koo Kang, Won Ki Kang, Jun Suk Kim, Yajie Wang, Thomas Leung

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Phase II study of irinotecan in combination with capecitabine as a first-line chemotherapy in Asian patients with inoperable hepatocellular carcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences